FindTrial
Sign In

A Study That Correlates The Diversity Of Micro-Organisms In Rectum Of Rectal Cancer Patients With The Clinical And Pathological Variables Of The Patient.

Clinico Pathological Correlation Of Diversity And Quantity Of Rectal Microbiota In Rectal Cancer Patients - A Metagenome Analysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028762
Enrollment
40
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum

Interventions

None listed

Sponsors

Regional Cancer CentreTrivandrum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis was confirmed by biopsy and histologic analysis

Exclusion criteria

Exclusion criteria: 1. Intestinal obstruction 2. Received Bowel preparation within past 14 days 3. Patients received preoperative chemotherapy or radiation therapy 4. Known lactose intolerance 5. Immunodeficiency 6. Inflammatory bowel disease 7. Received antibiotics with in past 3 months before sample collection 8. Evidence of infection 9. Probiotics or prebiotics usage within 2 weeks

Design outcomes

Primary

MeasureTime frame
To study the pattern and diversity of colonic microbiota in rectal cancer patients. To correlate clinico-pathological variables to colonic microbiota in rectal cancer patients Timepoint: At one month, six month and 1 year.—

Secondary

MeasureTime frame
To study the influence of colonic microbiota in immediate outcome of surgical treatment in rectal cancer patients Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Jino Sebastian

Regional Cancer Centre, Trivandrum.

dr.chandramohan@gmail.com9895774393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026